We are live on ! Find out more
NGNE icon

Neurogene
NGNE

36 hedge funds and large institutions have $14.3M invested in Neurogene in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more capital invested

Capital invested by funds: $10.5M → $14.3M (+$3.8M)

0.26% more ownership

Funds ownership: 1.76% → 2.02% (+0.26%)

8% less funds holding

Funds holding: 39 → 36 (-3)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
6
Reduced
9
Closed
8
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$873K
2
WSL
Western Standard LLC
California
+$706K
3
LCM
Lynx1 Capital Management
Puerto Rico
+$546K
4
AFA
Alta Fundamental Advisers
New York
+$73.5K
5
Citadel Advisors
Citadel Advisors
Florida
+$39.3K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$137K
2
BlackRock
BlackRock
New York
-$66K
3
BCM
Bridgeway Capital Management
Texas
-$52.5K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$40.7K
5
MA
MYDA Advisors
New York
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$6.84K – – –
Federated Hermes
27
Federated Hermes
Pennsylvania
$1.29K -$279 -17 -18%
Group One Trading
28
Group One Trading
Illinois
$1.25K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$1.25K – – –
UBS Group
30
UBS Group
Switzerland
$913 -$11.3K -690 -93%
FFA
31
Farther Finance Advisors
California
$830 +$820 +50 New
TC
32
Truvestments Capital
Florida
$768 – – –
JP Morgan Chase
33
JP Morgan Chase
New York
$185 – – –
National Bank of Canada
34
National Bank of Canada
Quebec, Canada
$144 +$148 +9 New
Barclays
35
Barclays
United Kingdom
$135 -$4.21K -257 -97%
BCM
36
Bridgeway Capital Management
Texas
– -$52.5K -3,750 Closed
MA
37
MYDA Advisors
New York
– -$28K -2,000 Closed
EWM
38
Endurance Wealth Management
Rhode Island
– -$14K -1,000 Closed
Janney Montgomery Scott
39
Janney Montgomery Scott
Pennsylvania
– -$14K -1,000 Closed
TSS
40
Two Sigma Securities
New York
– -$11.9K -850 Closed
CSS
41
Cubist Systematic Strategies
Connecticut
– -$9.41K -672 Closed
PCM
42
PenderFund Capital Management
British Columbia, Canada
– -$6K -335 Closed
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
– +$328 +20 +200%
1
2

NGNE Hedge Fund Activity: Q2 2023 in Review

36 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2023, worth a combined $14.3M — up 36% from $10.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NGNE and 5 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Redmile Group, adding an estimated $873K. The largest seller was Millennium Management, cutting an estimated $137K.

  • 36 institutional investors held Neurogene (NGNE) as of Q2 2023, down from 39 in Q1 2023.
  • Funds reported $14.3M of Neurogene stock for Q2 2023, up 36% quarter-over-quarter.
  • 5 funds opened new Neurogene positions in Q2 2023 and 8 closed out, a net change of -3 holders.
  • The largest Neurogene buyer in Q2 2023 was Redmile Group, an estimated $873K added.
  • The largest Neurogene seller in Q2 2023 was Millennium Management, an estimated $137K sold.

Based on aggregated 13F filings for Q2 2023.